| [1] |
Schmoll HJ, Van Cutsem E, Stein A，et al.ESMO Consensus Guidelines for management of patients with colon and rectal cancer.a personalized approach to clinical decision making.Ann Oncol，2012，23(10):2479-2516.
|
| [2] |
Adam R, Aloia T, Levi F，et al.Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.J Clin Oncol，2007，25(29):4593-4602.
|
| [3] |
Souglakos J, Androulakis N, Syrigos K，et al.FOLFOXIRI(folinic acid，5-fluorouracil，oxaliplatin and irinotecan)vs FOLFIRI(folinic acid，5-fluorouracil and irinotecan)as flrst-line treatment in metastatic colorectal cancer(MCC)：a multicentre randomised phase III trial from the Hellenic Oncology Research Group(HORG)．Br J Cancer，2006，94(6):798-805.
|
| [4] |
Saltz LB, Clarke S, Diaz-Rubio E，et al.Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer：a randomized phase III study.J Clin Oncol，2008，26(12):2013-2019.
|
| [5] |
Macedo LT, da Costa Lima AB, Sasse AD.Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer：a systematic review and meta-analysis，with emphasis on chemotherapy subgroups.BMC Cancer，2012，12(89)．
|
| [6] |
Gerlinger M1, Rowan AJ, Horswell S，et al.Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.N Engl J Med，2012，366(10):883-892.
|
| [7] |
Kreso A1, O'Brien CA, van Galen P，et al.Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer.Science，2013，339(6119):543-548.
|
| [8] |
Adam R, De Gramont A, Figueras J，et al.The oncosurgery approach to managing liver metastases from colorectal cancer：a multidisciplinary international consensus.Oncologist，2012，17(10):1225-1239.
|
| [9] |
Giessen C, Laubender RP, Fischer von Weikersthal L，et al.Early tumor shrinkage in metastatic colorectal cancer：retrospective analysis from an irinotecan-based randomized first-line trial.Cancer Sci，2013，104(6):718-724.
|
| [10] |
Modest DP, Laubender RP, Stintzing S，et al.Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX：an analysis of the German AIO KRK 0104 trial.Acta Oncol，2013，52(5):956-962.
|
| [11] |
Lordan JT, Karanjia ND, Quiney N，et al.A 10-year study of outcome following hepatic resection for colorectal liver metastases-The effect of evaluation in a multidisciplinary team setting.Eur J Surg Oncol，2009，35(3):302-306.
|
| [12] |
叶颖江，王杉．多学科专家组诊疗模式的组织和规范实施．中国实用外科杂志，2011，31(1):22-24.
|